Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

Hirsch, A.; Nijveldt, R.; Vleuten, P.A. van der; Tijssen, J.G.P.; Giessen, W.J. van der; Tio, R.A.; ... ; HEBE Investigators (2011)

Article / Letter to editor

• Cell therapy
• Myocardial infarction
• Magnetic resonance imaging
• Left ventricular function
• Remodelling

• All authors: Hirsch, A.; Nijveldt, R.; Vleuten, P.A. van der; Tijssen, J.G.P.; Giessen, W.J. van der; Tio, R.A.; Waltenberger, J.; Berg, J.M. ten; Doevendans, P.A.; Aengevaeren, W.R.M.; Zwaginga, J.J.; Biemond, B.J.; Rossum, A.C. van; Piek, J.J.; Zijlstra, F.; HEBE Investigators
• Date: 2011-07-31
• Journal: European Heart Journal
• Volume: 32
• Issue: 14
• Pages: 1736 - 1747
• DOI: doi:10.1093/eurheartj/ehq449